Cataflam
(diclofenac potassium)Phase 3Small molecule
NovartisDiclofenac potassium is used to relieve pain and reduce inflammation and fever. It works quickly and is commonly used for headaches, muscle aches, menstrual cramps, and other types of short-term pain.[1] Cataflam is currently being investigated across 9 indications[3], with its most advanced program in Phase 3.[1]
Cataflam is one of 219 small molecule programs targeting Migraine Disorder. It is currently in Phase 3.
9
Indications
23
Total Trials
3
Active Trials
218
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
449 competitors in Non-Small Cell Lung Cancer
#DrugCompanyPhaseTrials
1Trodelvy
GileadPhase 3
Cabometyx
Bristol-Myers SquibbPhase 3
Verzenio
Eli LillyPhase 3
Cataflam
NovartisPhase 3
Remeron
OOrganon and Co
Preclinical
Valemetostat Tosylate
Daiichi SankyoPreclinical
Aqupla
Jiangsu Simcere Pharmaceutical Co., Ltd.Preclinical
Ftorafur
TThe First Affiliated Hospital with Nanjing Medical University
Preclinical
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Treatment
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Pulpitis4 trials
Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis
Unknown status·—·Phase 2/3·NCT03163420·68 enrolled
Efficacy of Preoperative Diclofenac Potassium- Acetaminophen Combination on Anesthetic Success in Patients With Symptomatic Irreversible Pulpitis: a Randomized Controlled Trial
Unknown status·—·N/A·NCT04593160·72 enrolled
Show 1 more trial
Evaluation of the Effect of Intra-ligamentary Injection of Diclofenac Potassium Versus Articaine on Anaesthetic Efficacy in Mandibular Molars With Symptomatic Irreversible Pulpitis.
Not yet recruiting·—·Phase 1·NCT06500871·40 enrolled
Diclofenac3 trials
Respiratory tract infection2 trials
Analgesic Efficacy2 trials
9 more indications
Symptomatic Irreversible Pulpitis2 trials
Hysteroscopy1 trial
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
Completed·—·Phase 2/3·NCT02714699·129 enrolled
Non-Small Cell Lung Cancer1 trial
Efficacy and Safety1 trial
Sunburn1 trial
Dental Pain1 trial
Post Operative Pain1 trial
The Effect of Diclofenac Potassium Insitu Gel Vs Calcium Hydroxide as Intra-canal Medications on Post-operative Pain and Anti-bacterial Effect
Unknown status·—·N/A·NCT04622488·44 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for diclofenac potassium. EMBL-EBI & Wellcome Sanger Institute.
- [4]